Quiero saber acerca de...

52684

Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Notices
SUPPLEMENTARY INFORMATION:

Purpose: The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the CDC Director and appear on CDC immunization schedules must be covered by applicable health plans.
Matters To Be Considered: The agenda will include discussions on adult immunization schedule, child/
adolescent immunization schedule, Ebola vaccine, hepatitis vaccines, herpes zoster vaccines, Orthopoxviruses vaccine, influenza vaccines, pneumococcal vaccine, cholera vaccine and tickborne encephalitis vaccine.
Recommendation votes on adult immunization schedule, child/
adolescent immunization schedule, hepatitis vaccine, herpes zoster vaccine, Orthopoxviruses vaccine, pneumococcal vaccine and Ebola vaccine are scheduled. No Vaccines for Children votes are scheduled. Agenda items are subject to change as priorities dictate.
For more information on the meeting agenda visit https www.cdc.gov/
vaccines/acip/meetings/meetingsinfo.html.
Meeting Information: The meeting will be webcast live via the World Wide Web; for more information on ACIP
please visit the ACIP website: http
www.cdc.gov/vaccines/acip/index.html.
Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https www.regulations.gov.
Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display.
CDC will review all submissions and
VerDate Sep<11>2014

16:44 Sep 21, 2021

Jkt 253001

may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/
near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket.
Written Public Comment: The docket will be opened to receive written comments on October 1, 2021. Written comments must be received on or before October 21, 2021.
Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes including all votes relevant to the ACIPs Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment:
All persons interested in making an oral public comment at the October 2021, 2021 ACIP meeting must submit a request at http www.cdc.gov/vaccines/
acip/meetings/ no later than 11:59 p.m., EDT, October 18, 2021, according to the instructions provided.
If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session.
CDC staff will notify individuals regarding their request to speak by email by October 19, 2021. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to 3 minutes, and each speaker may only speak once per meeting.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
FR Doc. 202120476 Filed 92121; 8:45 am BILLING CODE 416318P

PO 00000

Frm 00053

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and Prevention Docket No. CDC20210089

Advisory Committee on Immunization Practices ACIP; Correction Notice of Meeting Centers for Disease Control and Prevention, Department of Health and Human Services.
ACTION: Notice.
AGENCY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention CDC, announces the following meeting of the Advisory Committee on Immunization Practices ACIP. This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: http www.cdc.gov/
vaccines/acip/index.html.
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the meeting of the Advisory Committee on Immunization Practices ACIP; August 30, 2021, 10:00 a.m. to 4:00 p.m., and August 31, 2021, 10:00 a.m. to 4:00
p.m., EDT times subject to change, in the amended FRN.
The virtual meeting was published in the Federal Register on Thursday, August 26, 2021, Volume 86, Number 163, pages 4764447645.
The virtual meeting is being corrected to change the dates and times, addresses and written public comment and should read as follows:
DATES: The meeting will be held on August 30, 2021, from 10:00 a.m. to 4:00
p.m., EDT times subject to change. The docket will close on August 30, 2021.
Written comments must be received on or before August 30, 2021.
A notice of this ACIP meeting has also been posted on CDCs ACIP website at:
http www.cdc.gov/vaccines/acip/
index.html. In addition, CDC has sent notice of this ACIP meeting by email to those who subscribe to receive email updates about ACIP. The meeting is open to the public.
ADDRESSES: You may submit comments, identified by Docket No. CDC2021
0089 by any of the following methods:
Federal eRulemaking Portal:
https www.regulations.gov. Follow the instructions for submitting comments.
Mail: Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H248, Atlanta, Georgia 30329
SUMMARY:

E:FRFM22SEN1.SGM

22SEN1